Two of the FDA's senior vaccine officials are leaving their positions as the agency mulls new rules and regulations over booster shots and Covid-19 vaccinations for children, according to Bloomberg and Endpoints News.
Departing the agency are Office of Vaccines Research and Review Director Marion Gruber, Ph.D. and Deputy Director Phillip Krause, M.D. Gruber plans to retire on Oct. 31, while Philips - deputy director for the FDA's Center for Biologics Evaluation and Research, will be leaving in November.
US FDA is losing two giants who helped bring us many safe and effective vaccines over decades of public service.
As Endpoints News notes, "A former senior FDA leader told Endpoints that they're departing because they're frustrated that CDC and their ACIP committee are involved in decisions that they think should be up to the FDA. The former FDAer also said he's heard they're upset with CBER director Peter Marks for not insisting that those decisions should be kept inside FDA. What finally did it for them was the White House getting ahead of FDA on booster shots."
Joe Biden wrecked the FDA. That was quick.
FDA's former acting chief scientist Luciana Borio added on Twitter, "FDA is losing two giants who helped bring us many safe and effective vaccines over decades of public service."
"These two are the leaders for Biologic review in the US. They have a great team, but these two are the true leaders of CBER. A huge global loss if they both leave," Former BARDA director Rick Bright wrote, weighing in on the news.
Tuesday, August 31, 2021
Two Senior FDA Officials Stepping Down Over Reported Disagreements With White House Over Booster Shots
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment